Mass spectrometry (MS) has become the gold-standard technology for unbiased, comprehensive analysis of post-translational modifications (PTMs) on histones, offering unparalleled precision and depth. CD BioSciences provides expert mass spectrometry profiling services specifically for histone modifications, enabling you to decode the complex epigenetic signatures that regulate chromatin function and cellular identity.
Mass spectrometry is an analytical technique that measures the mass-to-charge ratio (m/z) of ions to identify and quantify molecules with high accuracy and sensitivity. In histone PTM analysis, proteins are enzymatically digested into peptides, which are then ionized and separated based on their m/z in a mass analyzer. Tandem MS (MS/MS) fragments selected peptides, generating spectra that reveal amino acid sequences and the specific sites and types of modifications (e.g., +42 Da for acetylation, +14 Da for methylation). This approach allows for the simultaneous detection of multiple PTMs—including low-abundance and novel modifications—without the need for prior antibodies or assumptions, making it indispensable for mapping the complete "histone code" and understanding its dynamic regulation.

Fig.1 A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins. (Sidoli S, et al., 2019)

Mass spectrometry provides a powerful, versatile platform for epigenetic research by integrating several key features:
As a leading provider of epigenetic research services, CD BioSciences focuses on providing end-to-end mass spectrometry analysis services for the identification and quantification of histone PTMs. We combine advanced instrumentation, optimized histone-specific workflows, and expert bioinformatics to deliver robust, publication-ready data. Our services are designed to help you overcome the technical challenges of PTM analysis, from accurate site mapping to understanding the functional interplay between different modifications in your biological system.
We combine advanced high-resolution LC-MS/MS instrumentation with specialized histone-specific workflows—including optimized sample preparation, multiple fragmentation techniques (HCD/ETD/EThcD), and dedicated bioinformatics pipelines—to deliver unparalleled sensitivity, accuracy, and depth in PTM detection and quantification. This enables precise mapping of both canonical and novel modifications, even at low stoichiometry, providing robust data to decode the complex epigenetic landscape.

At CD BioSciences, we provide a complete, highly customizable mass spectrometry profiling solution for the identification and quantification of histone modifications. From routine analysis of common PTMs to the discovery and quantification of rare modifications, our tailored services are designed to meet the specific needs of your research project. We are committed to delivering data of the highest quality and biological relevance to accelerate your discoveries in chromatin biology and beyond. Contact us to discuss how we can support your next epigenetic research endeavor.
Reference
1. Sidoli S, Lopes M, Lund P J, et al. A mass spectrometry-based assay using metabolic labeling to rapidly monitor chromatin accessibility of modified histone proteins[J]. Scientific reports, 2019, 9(1): 13613.
USA
Quick Links
Easy access to products and services you need from our library via powerful searching tools
Privacy Policy | Cookie Policy
Copyright © 2026 CD BioSciences. All Rights Reserved.